Nexalin Technology Current Ratio Growth & History (NXL)
Nexalin Technology's current ratio was 4.85 for fiscal 2025.
View full Nexalin Technology company overviewNexalin Technology annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 4.85 | −2.40 | −33.13% |
| 2024 | 2024-12-31 | 7.25 | −0.82 | −10.16% |
| 2023 | 2023-12-31 | 8.07 | 4.26 | +111.68% |
| 2022 | 2022-12-31 | 3.81 | 3.49 | +1096.46% |
| 2021 | 2021-12-31 | 0.32 | — | — |
Nexalin Technology quarterly current ratio
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 1.25 | −9.18 | −87.99% |
| Q1 2026 | 2026-03-31 | 4.07 | −0.49 | −10.74% |
| Q4 2025 | 2025-12-31 | 4.85 | −2.40 | −33.13% |
| Q3 2025 | 2025-09-30 | 13.47 | −2.92 | −17.80% |
| Q2 2025 | 2025-06-30 | 10.44 | 4.86 | +87.29% |
| Q1 2025 | 2025-03-31 | 4.56 | −0.49 | −9.77% |
| Q4 2024 | 2024-12-31 | 7.25 | −0.82 | −10.16% |
| Q3 2024 | 2024-09-30 | 16.39 | 12.83 | +360.26% |
| Q2 2024 | 2024-06-30 | 5.57 | 1.25 | +28.94% |
| Q1 2024 | 2024-03-31 | 5.05 | 0.14 | +2.82% |
| Q4 2023 | 2023-12-31 | 8.07 | 4.26 | +111.68% |
| Q3 2023 | 2023-09-30 | 3.56 | −0.65 | −15.48% |
| Q2 2023 | 2023-06-30 | 4.32 | — | — |
| Q1 2023 | 2023-03-31 | 4.92 | — | — |
| Q4 2022 | 2022-12-31 | 3.81 | 3.49 | +1096.46% |
| Q3 2022 | 2022-09-30 | 4.21 | — | — |
| Q4 2021 | 2021-12-31 | 0.32 | — | — |
Nexalin Technology current ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, Nexalin Technology's current ratio increased from 0.32 to 4.85, a change of 4.53. The latest reported quarter, Q2 2026, shows 1.25.
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nexalin Technology source filings ↗